The Global Psoriasis Atlas will be the leading epidemiological resource on psoriasis globally; thus informing research, policy and health care worldwide.
To detail disease prevalence and incidence worldwide in order to determine the natural history and burden of psoriasis across the globe.
To provide data on the burden of psoriasis, including societal costs, comorbid diseases and patients’ access to treatment.
The Global Psoriasis Atlas (GPA) is a joint project of the ILDS (International League of Dermatological Societies), IFPA (International Federation of Psoriasis Associations ) and IPC (International Psoriasis Council).
The mission of the GPA is to provide the common benchmark on the complete burden of psoriasis in all countries and regions throughout the world. The GPA will leverage existing data from publications and registries; where gaps are identified additional studies will be commissioned. The GPA is a longterm project that seeks to drive continuous improvement in the understanding of psoriasis and to uncover how it affects both the individual and society at large. Whilst the first edition of the GPA will focus on the incidence and prevalence of psoriasis, future additions will be expanded to include access to treatment, comorbidities and cost to society. For more information visit the GPA website
Christopher EM Griffiths, OBE MD FRCP FMedSci University of Manchester Manchester, England, Great Britain (UK) IPC Board Member
Professor Christopher Griffiths is Director of the Manchester Centre for Dermatology Research and Head of the Dermatology Theme of the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre. He gained a 1st Class Hons BSc in Anatomy from St Thomas’ Hospital Medical School, London in 1976 and qualified in Medicine MB BS in 1979. Following junior hospital posts in South London he trained in Dermatology at St Mary’s Hospital, London (1983-87) where he was a Wellcome Trust Clinical Research Training Fellow (1985-87). In 1987 he took up a research fellowship in Dermatology at the University of Michigan, USA, and was appointed to Assistant Professorship on Faculty 1989-93. He was appointed to the Foundation Chair in Dermatology at the University of Manchester in 1994 and is an Honorary Consultant Dermatologist at Salford Royal NHS Foundation Trust. Professor Griffiths has received several medals and honors for his work in psoriasis, most recently, he was appointed an Officer of the Order of the British Empire (OBE), for services to dermatology, in the Queen’s 2018 New Year’s Honours. He is one of the co-founders of the International Psoriasis Council and past-President. He has also been President of the British Association of Dermatologists European Dermatology Forum and British Society for Investigative Dermatology.
Last Updated: 1/25/2018 12:00:00 AM
Darren Ashcroft, BPharm MSc PhD FRPharmS University of Manchester Manchester, England, Great Britain (UK)
Darren Ashcroft holds the Foundation Chair in Pharmacoepidemiology at the University of Manchester and is the founding Director of the Centre for Pharmacoepidemiology and Drug Safety. His major research interests focus on clinical epidemiology and pharmaceutical outcomes research, with particular interest in the comparative safety and effectiveness of pharmaceuticals and biotechnolgy products, drug policy and risk management program evaluation, and epidemiological methods using electronic healthcare databases. He has many years of experience working with large electronic healthcare databases in the UK, particularly the Clinical Practice Research Datalink (www.cprd.com). He is currently a coinvestigator on the MRC-funded Psoriasis Stratification to Optimise Relevant Therapy (PSORT) consortium.
Matthias Augustin, MD University Medical Center Hamburg-Eppendorf Hamburg, Germany
Professor Augustin, born 1962 in G̦ttingen, is professor for health economics and for dermatology at the University Medical Center Hamburg-Eppendorf. He is the Director of the Institute for Health Services Research in Dermatology and Nursing, Head of the Comprehensive Wound Center (CWC), Chair of the Center for Dermatological Research (CeDeF) and Chair of the German Center for Health Services Research in Dermatology (CVderm). Prof. Augustin is a founding member of the Hamburg Institute for Health Economics (HCHE), the largest Center for Health Economics in Germany. In his institute Prof. Augustin integrates clinical research, health services research and basic research with clinical practice. Special topics of research by Prof. Augustin are skin cancer, chronic inflammatory diseases, allergies and chronic wounds. A particular field of research is the European Dermatology Health Survey and the program CLIMAderm climate change and skin diseases. He is the editor, author or contributor of over 60 medical books and has authored about 350 scientific articles. Prof. Augustin is a senior consultant to the German Ministry of Health, to several Statutory health insurance companies and to a large number of companies in the health sector. He has been an expert to the German National Parliament (Bundestag), and he is the spokesman of the German Society for Dermatology to the German Federal Joint Committee (GBA) and to the Institute for Quality and Efficiency in Medicine (IQWiG).
Last Updated: 9/18/2018 12:00:00 AM
C.E.M. Griffiths, J.M. van der Walt, D.M. Ashcroft, C. Flohr, L. Naldi, T. Nijsten, M. Augustin, Br J Dermatol. 2017 Jul;177(1):e4-e7. doi: 10.1111/bjd.15610. 28555722
Abstract
The International Psoriasis Council, a global nonprofit organization dedicated to innovation across the full spectrum of psoriasis, led a symposium to discuss the current state of psoriasis epidemiology and to introduce the vision and development of a Global Psoriasis Atlas. The symposium was held on 9 September 2015 at the 45th annual meeting of the European Society for Dermatological Research, Rotterdam, the Netherlands. Collectively, these presentations highlighted challenges associated with assessing psoriasis epidemiology and emphasized the urgent need for an authoritative resource to clarify psoriasis disease burden on a global scale.
Link to full article